Diabetes mellitus does not adversely affect outcomes from a critical illness

Critical Care Medicine

Volumn 38, Issue 1, 2010, Pages 16-24

  Graham, Brian B ^a   Keniston, Angela ^b   Gajic, Ognjen ^c   Trillo Alvarez, Cesar A ^c   Medvedev, Sofia ^d   Douglas, Ivor S ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d University HealthSystem Consortium   (United States)

Author keywords

Critical illness; Diabetes mellitus; Outcome predictor

Indexed keywords

ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FACTUAL DATABASE; FEMALE; HOSPITAL ADMISSION; MALE; MIDDLE AGED; NEOPLASM; PROGNOSIS; RISK; RISK ASSESSMENT; SEX RATIO; STATISTICAL MODEL; STATISTICS; SURVIVAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CRITICAL ILLNESS; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 74049144410     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b9eaa5     Document Type: Article

References (46)

1. World Health Organization. Diabetes Programme. Country and regional data. World Health Organization Web site. http://www. who.int/diabetes/facts/world figures/en (Accessed June 25, 2007)
2. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31:596-615
3. Nathan DM, Cleary PA, Backlund JY, et al: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653
4. Bucerius J, Gummert JF, Walther T, et al: Impact of diabetes mellitus on cardiac surgery outcome. Thorac Cardiovasc Surg 2003; 51:11-16
5. Bochicchio GV, Joshi M, Bochicchio K, et al: Incidence and impact of risk factors in critically ill trauma patients. World J Surg 2006; 30:114-118 (Pubitemid 43081622)
6. Christiansen C, Toft P, Jorgensen HS, et al: Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 2004; 30:1685-1688
7. Sung J, Bochicchio GV, Joshi M, et al: Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 59:80-83 (Pubitemid 41271642)
8. Krinsley JS: Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: Six and one-half years experience at a university-affiliated community hospital. Seminars in thoracic and cardiovascular. Surgery 2006; 18: 317-325
9. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
10. Ligtenberg JJ, Meijering S, Stienstra Y, et al: Mean glucose level is not an independent risk factor for mortality in mixed ICU patients. Intensive Care Med 2006; 32:435-438
11. Freire AX, Bridges L, Umpierrez GE, et al: Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 2005; 128: 3109-3116
12. Whitcomb BW, Pradhan EK, Pittas AG, et al: Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005; 33: 2772-2777
13. Egi M, Bellomo R, Stachowski E, et al: Blood glucose concentration and outcome of critical illness: The impact of diabetes. Crit Care Med 2008; 36:2249-2255
14. Rady MY, Johnson DJ, Patel BM, et al: Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes melli-tus. Mayo Clin Proc 2005; 80:1558-1567
15. Martin GS, Mannino DM, Moss M: The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34:15-21
16. Esper AM, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis: An epidemiological study. Crit Care 2009; 13:R18
17. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
18. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
19. Michalia M, Kompoti M, Koutsikou A, et al: Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med 2009; 35:448-454
20. Garg R, Chaudhuri A, Munschauer F, et al: Hyperglycemia, insulin, and acute ischemic stroke: A mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37: 267-273
21. Goldfarb M, Rosenberger C, Abassi Z, et al: Acute-on-chronic renal failure in the rat: Functional compensation and hypoxia tolerance. Am J Nephrol 2006; 26:22-33
22. Wright JK, Nwariaku FN, Clark J, et al: Effect of diabetes mellitus on endotoxin-induced lung injury. Arch Surg 1999; 134:1354-1358; discussion 8-9
23. Moss M, Guidot DM, Steinberg KP, et al: Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000; 28:2187-2192
24. Gong MN, Thompson BT, Williams P, et al: Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005; 33:1191-1198
25. Drachman DA. Benchmarking patient satisfaction at academic health centers. Jt Comm J Qual Improv 1996; 22:359-367
26. Afessa B, Keegan MT, Hubmayr RD, et al: Evaluating the performance of an institution using an intensive care unit benchmark. Mayo Clin Proc 2005; 80:174-180
27. 3M. APR DRG classification system. 3M Web site. http://solutions.3m.com/ wps/portal/3M/ en-US/3MHIS/HealthInformationSystems/ HIS/Products/APDRG- software. Accessed September 22, 2009
28. University HealthSystem Consortium. Risk adjustment methodology for the clinical data base. http://www.denverhealth.org/portal/ Portals/0/docs/dept- medicine/UHC%20Risk% 20Adjustment%20Methodology.pdf. Accessed October 5, 2008
29. Zimmerman JE, Wagner DP, Draper EA, et al: Evaluation of acute physiology and chronic health evaluation III predictions of hospital mortality in an independent database. Crit Care Med 1998; 26:1317-1326
30. Peake SL, Moran JL, Ghelani DR, et al: The effect of obesity on 12-month survival following admission to intensive care: A prospective study. Crit Care Med 2006; 34: 2929-2939
31. O'Brien JM Jr, Lu B, Ali NA, et al: Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 2007; 35:345-350
32. Stranders I, Diamant M, van Gelder RE, et al: Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164:982-988
33. Ishihara M, Kagawa E, Inoue I, et al: Impact of admission hyperglycemia and diabetes mellitus on short-and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 2007; 99:1674-1679
34. Ketonen M, Pajunen P, Koukkunen H, et al: Long-term prognosis after coronary artery bypass surgery. Int J Cardiol 2008; 124: 72-79
35. Bucerius J, Gummert JF, Walther T, et al: Diabetes in patients undergoing coronary artery bypass grafting. Impact on perioperative outcome. Z Kardiol 2005; 94:575-582
36. Rajakaruna C, Rogers CA, Suranimala C, et al: The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg 2006; 132:802-810
37. Furnary AP, Gao G, Grunkemeier GL, et al: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Car-diovasc Surg 2003; 125:1007-1021
38. Furnary AP, Wu Y. Clinical effects of hyper-glycemia in the cardiac surgery population: The Portland Diabetic Project. Endocr Pract 2006; 12 Suppl 3:22-26
39. Coughlan MT, Permezel M, Georgiou HM, et al: Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cy-tokine responses in gestational diabetes. J Clin Endocrinol Metab 2004; 89:3585-3594
40. Piette JD, Wagner TH, Potter MB, et al: Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care 2004; 42:102-109
41. Weant KA, Cook AM. Potential roles for statins in critically ill patients. Pharmacotherapy 2007; 27:1279-1296
42. Mortensen EM, Restrepo MI, Anzueto A, et al: The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC Pulm Med 2005; 5:12
43. Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006; 29:109-117
44. Fox CS, Pencina MJ, Meigs JB, et al: Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: The Framing-ham Heart Study. Circulation 2006; 113: 2914-2918
45. Narayan KM, Boyle JP, Thompson TJ, et al: Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290:1884-1890
46. Fontaine KR, Redden DT, Wang C, et al: Years of life lost due to obesity. JAMA 2003; 289:187-193